<DOC>
	<DOCNO>NCT00469131</DOCNO>
	<brief_summary>The aim study compare immunosuppression protocol tacrolimus + MMF tacrolimus + steroid prevent recurrence hepatitis C living donor liver transplantation .</brief_summary>
	<brief_title>Effects Immunosuppression HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF Tacrolimus + Steroid</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Recipient living donor liver transplantation HCVrelated cirrhosis ABO blood type incompatible transplant case Renal dysfunction ( serum creatinine &gt; 2.0 mg/dL ) WBC &lt; 1,000/mm3 Hemoglobin &lt; 8 g/dL Platelet &lt; 30,000 /mm3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>liver transplantation ,</keyword>
	<keyword>HCV recurrence ,</keyword>
	<keyword>immunosuppression</keyword>
</DOC>